Fig. 2From: Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practicea Change in size of largest rAML from the baseline to the last imaging (n = 29). b Mean diameter change in largest rAML size in both kidneys from the baseline to the last imaging (n = 29)Back to article page